Corvus Pharmaceuticals (CRVS) Cash from Investing Activities (2015 - 2026)
Corvus Pharmaceuticals' Cash from Investing Activities came in at -$5.97 million for Q2 2026, compared with -$20.3 million a year earlier.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Corvus Pharmaceuticals reported Cash from Investing Activities of -$142.55 million; for FY2025, it was -$7.8 million.
- Going back by year, Cash from Investing Activities was -$27.48 million in FY2024, $15.54 million in FY2023, -$23.28 million in FY2022 and $21.56 million in FY2021 (-51.8%).
- The five-year range for quarterly Cash from Investing Activities is -$144.85 million (Q1 2026) to $17.55 million (Q3 2023).
- Business Quant data shows CRVS's Cash from Investing Activities at -$144.85 million (Q1 2026), $10.88 million (Q4 2025) and -$2.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Corvus Pharmaceuticals | 916.92 Mn | 405.36 Mn | - | -5.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.97 Mn |
| Mar 31, 2026 | -144.85 Mn |
| Dec 31, 2025 | 10.88 Mn |
| Sep 30, 2025 | -2.62 Mn |
| Jun 30, 2025 | -20.30 Mn |
| Mar 31, 2025 | 4.24 Mn |
| Dec 31, 2024 | -6.08 Mn |
| Sep 30, 2024 | -3.89 Mn |
| Jun 30, 2024 | -17.50 Mn |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | -2.32 Mn |
| Sep 30, 2023 | 17.55 Mn |
| Jun 30, 2023 | -4.29 Mn |
| Mar 31, 2023 | 4.60 Mn |
| Dec 31, 2022 | -3.88 Mn |
| Sep 30, 2022 | 3.04 Mn |
| Jun 30, 2022 | 3.14 Mn |
| Mar 31, 2022 | -25.57 Mn |
| Dec 31, 2021 | -2.00 Mn |
| Sep 30, 2021 | 3.47 Mn |
API Access
Corvus Pharmaceuticals Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();